Global economic concerns weighed the markets down to a flat close the Dow holding steady at 12,815. Nasdaq held steady at 2904. On the upside
Sarepta Therapeutics (NYSE: SRPT) reported upbeat results from a Phase II clinical trial of its Duchenne muscular dystrophy treatment eteplirsen at the Action Duchenne meeting. China Digital TV (NYSE: STV) declared a special cash dividend of $2.30 per share payable in two installments on December 3, 2012 and February 4, 2013 to shareholders of record November 26, 2012. Sherwin-Williams (NYSE: SHW) will pay approximately $2.34 billion in cash to acquire privately held Consorcio Comex.On the downside Jefferies downgraded Nektar Therapeutics (Nasdaq: NKTR) to a Hold rating. Gilead's (Nasdaq: GILD) upbeat trial results for its hepatitis C treatment weighed down share of Achillion (Nasdaq: ACHN), which is developing its own hepatitis C drug. Morgan Stanley downgraded Inteliquent (NYSE: IQNT) to an Underweight rating. In the broad market, declining issues outpaced advancers by a margin of more than 19 to 9 on the NYSE and by nearly 5 to 4 on Nasdaq. The Russell 2000 which tracks small cap stocks slipped a point to 793.